Clinical trial

Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00616031

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE2

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2013-08-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

carboplatinDRUG · verified · RxNorm: carboplatin

nitroglycerinDRUG · verified · RxNorm: nitroglycerin

paclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

Kyoto Universitylead sponsor

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00616031 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.